An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs ...

Leaders must re-examine the healthcare supply network and shift the focus from cost savings to building resilience—all while ...

Three years ago, as the pandemic caused chaos for companies big and small, Colgate-Palmolive’s chief supply chain officer ...

The National Association of Wholesaler-Distributors (NAW), in collaboration with MDM Research, released new survey results on the impact of tariffs on the supply chain. Based on responses from more ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

Natasha Mohan, a professional in cloud infrastructure, delves into the intricate supply chain that underpins cloud technology, examining groundbreaking advancements in hardware architecture, ...

His research, grounded in industrial engineering, tackles the pressing challenges of supply chain resilience, operational efficiency, and humanitarian aid delivery, offering data-driven frameworks ...

LONDON (Reuters) - German sportswear brand Puma (OTC:PMMAF) has reduced the amount of merchandise it ships to the United States from China to adapt its supply chain to tariffs, and could increase ...

With everything going on in international trade, it might be tempting to take your eye off the ball when it comes to environmental, social and governance issues. But ESG is here to stay. Hear from top ...

Altimmune and Viking Therapeutics have promising obesity drugs and could be great acquisition targets for Pfizer. Pfizer should be able to easily fund an acquisition of either small drugmaker.